Proangiogenic hematopoietic cells of monocytic origin: Roles in vascular regeneration and pathogenic processes of systemic sclerosis

Histology and Histopathology

Volumn 28, Issue 2, 2013, Pages 175-183

  Yamaguchi, Yukie ^a   Kuwana, Masataka ^b  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Endothelial progenitor cells; Monocytes; Scleroderma; Vasculogenesis

Indexed keywords

CD14 ANTIGEN;

ANGIOGENESIS; BLOOD VESSEL; CELL DIFFERENTIATION; CYTOLOGY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGY; METABOLISM; MONOCYTE; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION; REVIEW; SYSTEMIC SCLEROSIS; VASCULAR ENDOTHELIUM;

ANTIGENS, CD14; BLOOD VESSELS; CELL DIFFERENTIATION; ENDOTHELIUM, VASCULAR; HEMATOPOIETIC STEM CELLS; HUMANS; MONOCYTES; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATION; SCLERODERMA, SYSTEMIC;

EID: 84873878386     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Abe R., Donnelly S.C., Peng T., Bucala R. and Metz C.N. (2001). Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 166, 7556-7562.
2. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G. and Isner J.M. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967.
3. Avouac J., Juin F., Wipff J., Couraud P., Chiocchia G., Kahan A., Boileau C., Uzan G. and Allanore Y. (2008). Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity. Ann. Rheum. Dis. 67, 1455-1460.
4. Badorff C., Brandes R.P., Popp R., Rupp S., Urbich C., Aicher A., Fleming I., Busse R., Zeiher A.M. and Dimmeler S. (2003). Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107, 1024-1032.
5. Bellik L., Musilli C., Vinci M.C., Ledda F. and Parenti A. (2008). Human mature endothelial cells modulate peripheral blood mononuclear cell differentiation toward an endothelial phenotype. Exp. Cell Res. 314, 2965-2974.
6. Bucala R., Spiegel L.A., Chesney J., Hogan M. and Cerami A. (1994). Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med. 1, 71-81.
7. Campioni D., Lo Monaco A., Lanza F., Moretti S., Ferrari L., Fotinidi M., La Corte R., Cuneo A. and Trotta F. (2008). CXCR4+ circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis. Haematologica 93, 1233-1237.
8. Cipriani P., Franca Milia A., Liakouli V., Pacini A., Manetti M., Marrelli A., Toscano A., Pingiotti E., Fulminis A., Guiducci S., Perricone R., Kahaleh B., Matucci-Cerinic M., Ibba-Manneschi L. and Giacomelli R. (2006). Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications. Arthritis Rheum. 54, 3022-3033.
9. Curnow S.J., Marianne F., Schmutz C., Kissane S., Denniston A.K.O., Nash K., Buckley C.D., Lord J.M. and Salmon M. (2010). Distinct types of fibrocyte can differentiate from mononuclear cells in the presence and absence of serum. PLoS ONE. 5, 3;e9730.
10. D'Alessio S., Fibbi G., Cinelli M., Guiducci S., Del Rosso A., Margheri F., Serratì S., Pucci M., Kahaleh B., Fan P., Annunziato F., Cosmi L., Liotta F., Matucci-Cerinic M. and Del Rosso M. (2004). Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis. Arthritis Rheum. 50, 3275-3285.
11. Del Papa N., Quirici N., Soligo D., Scavullo C., Cortiana M., Borsotti C., Maglione W., Comina D.P., Vitali C., Fraticelli P., Gabrielli A., Cortelezzi A. and Lambertenghi-Deliliers G. (2006). Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum. 54, 2605-2615.
12. Diaz-Flores L., Gutierrez R., Madrid J.F., Varela H., Valladares F., Acosta E., Martin-Vasallo P. and Diaz-Flores Jr L. (2009). Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol. Histopathol. 24, 909-969.
13. Dimmeler S., Aicher A., Vasa M., Mildner-Rihm C., Adler K., Tiemann M., Rütten H., Fichtlscherer S., Martin H. and Zeiher A.M. (2001). HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest. 108, 391-397.
14. Distler O., Pap T., Kowal-Bielecka O., Meyringer R., Guiducci S., Landthaler M., Schölmerich J., Michel B.A., Gay R.E., Matucci-Cerinic M., Gay S. and Müller-Ladner U. (2001). Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis Rheum. 44, 2665-2678.
15. Elsheikh E., Uzunel M., He Z., Holgersson J., Nowak G. and Sumitran-Holgersson S. (2005). Only a specific subset of human peripheralblood monocytes has endothelial-like functional capacity. Blood 106, 2347-2355.
16. Estes M.L., Mund J.A., Ingram D.A. and Case J. (2010). Identification of endothelial cells and progenitor cell subsets in human peripheral blood. Curr. Protoc. Cytom. 52, 9.33.1-9.33.11.
17. Fernandez P.B., Lucibello F.C., Gehling U.M., Lindemann K., Weidner N., Zuzarte M.L., Adamkiewicz J., Elsässer H.P., Müller R. and Havemann K. (2000). Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65, 287-300.
18. Fischer C., Schneider M. and Carmeliet P. (2006) Principles and therapeutic implications of angiogenesis, vasculogenesis and arteriogenesis. Handb. Exp. Pharmacol. 176, 157-212.
19. Fleming J.N., Nash R.A., McLeod D.O., Fiorentino D.F., Shulman H.M., Connolly M.K., Molitor J.A., Henstorf G., Lafyatis R., Pritchard D.K., Adams L.D., Furst D.E. and Schwartz S.M. (2008). Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? PLoS One 3, e1452.
20. Fujiyama S., Amano K., Uehira K., Yoshida M., Nishiwaki Y., Nozawa Y., Jin D., Takai S., Miyazaki M., Egashira K., Imada T., Iwasaka T. and Matsubara H. (2003). Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ. Res. 93, 980-989.
21. Giusti B., Serratì S., Margheri F., Papucci L., Rossi L., Poggi F., Magi A., Del Rosso A., Cinelli M., Guiducci S., Kahaleh B., Matucci-Cerinic M., Abbate R., Fibbi G. and Del Rosso M. (2005). The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis. Arthritis Rheum. 52, 3618-3628.
22. Guiducci S., Giacomelli R. and Matucci-Cerinic M. (2007). Vascular complications of scleroderma. Autoimmun. Rev. 6, 520-523.
23. Heil M. and Schaper W. (2004). Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ. Res. 95, 449-458.
24. Herrick A. and Cutolo M. (2010). Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis. Arthritis Rheum. 62, 2595-2604.
25. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A. and Finkel T. (2003). Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348, 593-600.
26. Hirschi K.K., Ingram D.A. and Yoder M.C. (2008). Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 28, 1584-1595.
27. Ingram D.A., Mead L.E., Tanaka H., Meade V., Fenoglio A., Mortell K., Pollok K., Ferkowicz M.J., Gilley D. and Yoder M.C. (2004). Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104, 2752-2760.
28. Kodama H., Inoue T., Watanabe R., Yasuoka H., Kawakami Y., Ogawa S., Ikeda Y., Mikoshiba K. and Kuwana M. (2005). Cardiomyogenic potential of mesenchymal progenitors derived from human circulating CD14+ monocytes. Stem Cell Dev. 14, 676-686.
29. Kodama H., Inoue T., Watanabe R., Yasutomi D., Kawakami Y., Ogawa S., Mikoshiba K., Ikeda Y. and Kuwana M. (2006). Neurogenic potential of progenitors derived from human circulating CD14+ monocytes. Immunol. Cell Biol. 84, 209-217.
30. Kuwana M. and Okazaki Y. (2012). Quantification of circulating endothelial progenitor cells in systemic sclerosis: a direct comparison of protocols. Ann. Rheum. Dis. 71, 617-620.
31. Kuwana M., Okazaki Y., Kodama H., Izumi K., Yasuoka H., Ogawa Y., Kawakami Y. and Ikeda Y. (2003). Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J. Leukoc. Biol. 74, 833-845.
32. Kuwana M., Okazaki Y., Yasuoka H., Kawakami Y. and Ikeda Y. (2004). Defective vasculogenesis in systemic sclerosis. Lancet 364, 603-610.
33. Kuwana M., Okazaki Y., Kodama H., Satoh T., Kawakami Y. and Ikeda Y. (2006). Endothelial differentiation potential of human monocytederived multipotential cells. Stem Cells 24, 2733-2743.
34. LeRoy E.C. (1996). Systemic sclerosis: a vascular perspective. Rheum. Dis. Clin. North Am. 22, 675-694.
35. Liakouli V., Cipriani P., Marrelli A., Alvaro S., Ruscitti P. and Giacomelli R. (2011). Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun. Rev. 110, 590-594.
36. Liu X., Zhu S., Wang T., Hummers L., Wigley F.M., Goldschmidt-Clermont P.J. and Dong C. (2005). Paclitaxel moderates TGF' signaling in scleroderma skin grafts in immunodeficient mice. PLoS Med. 2, e354.
37. Manetti M., Guiducci S., Ibba-Manneschi L. and Matucci-Cerinic M. (2010). Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. J. Cell Mol. Med. 14, 1241-1254.
38. Manetti M., Guiducci S., Romano E., Ceccarelli C., Bellando-Randone S., Conforti M.L., Ibba-Manneschi L. and Matucci-Cerinic M. (2011). Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis. Circ. Res. 109, e14-26.
39. Margheri F., Manetti M., Serratì S., Nosi D., Pucci M., Matucci-Cerinic M., Kahaleh B., Bazzichi L., Fibbi G., Ibba-Manneschi L. and Del Rosso M. (2006). Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, '2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells. Arthritis Rheum. 54, 3926-3938.
40. Mathai S.K., Gulati M., Peng X., Russell T.R., Shaw A.C., Rubinowitz A.N., Murray L.A., Siner J.M., Antin-Ozerkis D.E., Montgomery R.R., Reilkoff R.A., Bucala R.J. and Herzog E.L. (2010). Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab. Invest. 90, 812-823.
41. Mok M.Y., Yiu K.H., Wong C.Y., Qiuwaxi J., Lai W.H., Wong W.S., Tse H.F. and Lau C.S. (2010). Low circulating level of CD133+KDR+ cells in patients with systemic sclerosis. Clin. Exp. Rheumatol. 28, S19-S25.
42. Medina R.J., O'Neill C.L., Sweeney M., Guduric-Fuchs J., Gardiner T.A., Simpson D.A. and Stitt A.W. (2010). Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Medical Genomics 3, 18.
43. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., Oz M.C., Hicklin D.J., Witte L., Moore M.A. and Rafii S. (2000). Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95, 952-958.
44. Prater D.N., Case J., Ingram D.A. and Yoder M.C. (2007). Working hypothesis to redefine endothelial progenitor cells. Leukemia 21, 1141-1149.
45. Rajantie I., Ilmonen M., Alminaite A., Ozerdem U., Alitalo K. and Salven P. (2004). Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 104, 2084-2086.
46. Rehman J., Li J.L., Orschell C.M. and March K.L. (2003). Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107, 1164-1169.
47. Ribatti D., Cantatore F.P., Vacca A., D'Amore M., Ria R., Roncali L. and Pipitone V. (1998). Systemic sclerosis stimulates angiogenesis in the chick embryo chorioallantoic membrane. Clin. Rheumatol. 17, 115-120.
48. Richardson M.R. and Yoder M.C. (2011). Endothelial progenitor cells: Quo Vadis? J. Mol. Cell Cardiol. 50, 266-272.
49. Rohde E., Malischnik C., Thaler D., Maierhofer T., Linkesch W., Lanzer G., Guelly C. and Strunk D. (2006). Blood monocytes mimic endothelial progenitor cells. Stem Cells 24, 357-367.
50. Romagnani P., Annunziato F., Liotta F., Lazzeri E., Mazzinghi B., Frosali F., Cosmi L., Maggi L., Lasagni L., Scheffold A., Kruger M., Dimmeler S., Marra F., Gensini G., Maggi E. and Romagnani S. (2005). CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ. Res. 97, 314-322.
51. Sakai N., Wada T., Fruichi K., Shimizu K., Kokubo S., Hara A., Yamahana J., Okumura T., Matsushima K., Yokoyama H. and Kaneko S. (2006). MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes. J. Leukoc. Biol. 79, 555-563.
52. Schmeisser A., Garlichs C.D., Zhang H., Eskafi S., Graffy C., Ludwig J., Strasser R.H. and Daniel W.G. (2001). Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc. Res. 49, 671-680.
53. Semenza G.L. (2007). Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. J. Cell Biochem. 102, 840-847.
54. Seta N. and Kuwana M. (2007). Human circulating monocytes as multipotential progenitors. Keio J. Med. 56, 41-47.
55. Seta N. and Kuwana M. (2010). Derivation of multipotent progenitors from human circulating CD14+ monocytes. Exp. Hematol. 38, 557-563.
56. Strieter R.M., Gomperts B.N. and Keane M.P. (2007). The role of CXC chemokines in pulmonary fibrosis. J. Clin. Invest. 117, 549-556.
57. Urbich C. and Dimmeler S. (2004). Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95, 343-353.
58. Urbich C., Heeschen C., Aicher A., Dernbach E., Zeiher A.M. and Dimmeler S. (2003). Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108, 2511-2516.
59. Urbich C., Aicher A., Heeschen C., Dernbach E., Hofmann W.K., Zeiher A.M. and Dimmeler S. (2005). Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell Cardiol. 39, 733-742.
60. Watt S.M., Athanassopoulos A., Harris A.L. and Tsaknakis G. (2010). Human endothelial stem/progenitor cells, angiogenic factors and vascular repair. J. R. Soc. Interface 7, S731-S751.
61. Yamaguchi Y., Okazaki Y., Seta N., Satoh T., Takahashi K., Ikezawa Z. and Kuwana M. (2010). Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis. Arthritis Res. Ther. 12, R205.
62. Yoder M.C. (2010). Is endothelium the origin of endothelial progenitor cells? Arterioscler. Thromb. Vasc. Biol. 30, 1094-1103.
63. Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., Krasich R., Temm C.J., Prchal J.T. and Ingram D.A. (2007). Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109, 1801-1809.
64. Zhao Y., Glesne D. and Huberman E. (2003). A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc. Natl. Acad. Sci. USA 100, 2426-2431.
65. Zhu S., Evans S., Yan B., Povsic T.J., Tapson V., Goldschmidt-Clermont P.J. and Dong C. (2008). Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells. Circulation 118, 2156-2165.